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and USP20 could function to reverse β2AR ubiquitination and thus, 
could be involved in the regulation of receptor traf cking. Indeed, 
coexpression of the β2AR with USP33 or USP20 (USP33/20) results 
in a dramatic reduction of isoproterenol-stimulated ubiquitination 
of the receptor. In contrast, similar coexpression of catalytically 
inactive USP33/20 mutants, which retains receptor binding, does 
not lead to any decrease in receptor ubiquitination. When HEK-293 
cells expressing the β2AR are exposed to 10 m isoproterenol for 
6h, internalized β2ARs are found to colocalize with the lysosomal 
marker protein, LAMP2. Wild type USP33/20, but not the catalytically 
inactive mutants expression abolishes this colocalization. Moreover, 
in the presence of USP33/20, β2ARs are found to be redirected to 
the plasma membrane even in the continued presence of agonist 
thus inhibiting lysosomal traf cking while concomitantly promoting 
receptor recycling from the late endosomal compartments as well as 
resensitization of recycled receptors at the cell surface. Inhibition 
of both USP20 and USP33 expression by SiRNA prevents completely 
the recycling and resensitization of the receptor whereas inhibition 
of only one of the two enzymes does not. Finally, dissociation of 
constitutively bound USP20 and USP33 from the β2-AR immediately 
after agonist-stimulation and re-association upon prolonged agonist 
treatment allows receptors to  rst become ubiquitinated and then 
deubiquitinated thus providing a “trip switch” between degradative 
and recycling pathways at the late endosomal compartments. 
In conclusion, our results suggest that by de-ubiquitinating the 
internalized β2ARs, USP20 and USP33 prevent their lysosomal 
traf cking and promotes receptor recycling and resensitization to the 
plasma membrane. USP20 and USP33 thus serve as novel regulators 
that dictate both post-endocytic sorting as well as the intensity and 
extent of β2-AR signalling from the cell surface.ββ
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Cardiac automaticity, in normal conditions, is generated by the 
Sinoatrial Node (SAN) tissue.
In the last years, two pacemaker mechanisms are proposed: the 
“ion channels clock”, based on the If current and the intracellular 
SR-dependent “Ca2+ clock”, based on spontaneous diastolic Ca2+ 
release. In our opinion a relevant role is played also by the Cav1.3 
(L-type Ca2+ current) and Cav3.1 (T-type Ca2+ current) channels. 
For this reason we studied the two mouse models Cav1.3 KO and 
Cav1.3/Cav3.1 double KO in vivo and in vitro. Electrocardiograms 
analysis showed a strong bradycardia (p<0.01). Respectively the 
Heart Rate (HR) of Cav1.3 KO and Cav1.3/Cav3.1 double KO are: 
396.3 ± 39.4 bpm (N.4) and 360.9 ± 53.1 bpm (N.3); instead in 
WT the HR is 545.4 ± 29.6 bpm (N.9). In addition we detected in 
the two mouse model a marked arrhythmia determined by the 
presence of many blocks of  rst and second degree. Particularly 
Cav1.3/Cav3.1 double KO showed a dissociation of rhythm.
In vitro analysis was performed with the line scan technique on WT 
and Cav1.3 KO SAN cells to observe the dynamics of Ca2+ release. The 
results seem to indicate a difference in the frequency of transients 
that is reduced in Cav1.3 KO compared with WT. Moreover the 
transient length result to be longer in Cav1.3 KO 1248.9 ± 341.5 ms 
(N.8) than in WT 831.7 ± 259.7 ms (N.5). Interesting results are 
obtained also after the analysis of the differents parts of transient, 
as expected the recovery phase result longer in Cav1.3 KO 1053.5 ± 
313.3 ms (N.5) than in WT 553.9 ± 178.5 ms (N.8), instead the ramp 
phase result longer in WT 192.5 ± 72.18 ms (N.8) than in Cav1.3 KO 
83.25 ± 38 ms (N.5).
In conclusion our date indicate that the absence of Cav1.3 channel 
cause the slowdown of pace maker mechanism at the in vivo and in 
vitro level. More experiments are needed to draw clears conclusions 
about the role of Cav3.1 channel, but seem to be important in 
cardiac automaticity generation.
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Aim — To investigate the effects of different agonist for the 
muscarinic receptor on cardiac automaticity in Cav1.3-/-, Kir 3.4-
/- and Cav1.3-/-Kir3.4-/- mice.
Method — In vivo: mice received methoxamine or CCPA once intra-
peritoneally and telemetric recordings were run continuously 
over 8 h. Quantitative ECG analyses were performed. In vitro: 
action potentials were recorded in isolated SAN cells before and 
after application of different doses of Ach, the variation in the 
spontaneous  ring rate was evaluated.
Result — In vivo: in WT, in Cav1.3-/- and in Cav1.3-/-Kir3.4-/- mice, 
methoxamine (6 mg/kg) reduces the HR (p<0.05) of 35 %, 53 % and 
48 %, respectively, but it has not effect on Kir 3.4-/- mice. CCPA 
0.01 mg/kg and 0.05 mg/kg have not effect on HR in all the mouse 
strains tested. CCPA 0.1 mg/kg reduces (p<0.05) the HR in WT, 
Cav1.3-/- and Cav1.3-/-Kir3.4-/- of 35 %, 49 % and 46 % respectively, 
but not in Kir 3.4-/- mice.
In vitro: the pacemaker activity in WT SAN cells is strongly reduced 
with 10 nM Ach (42 %, p<0.01) and it is stopped with 50 nM Ach, but 
it is not affected using 3 nM Ach. In Cav1.3-/-Kir3.4-/- cells, Ach has 
no effect (p>0.05) at each of the three doses tested. Concerning 
Kir3.4-/- cells, we have seen a reduction (p<0.05) of the  ring rate 
both a 10 nM (18 %) and at 50 nM (25 %).
Conclusion — In vivo: Inactivation of Cav1.3 exacerbated the 
slowing of HR induced by agonists of the muscarinic signalling 
pathway in both Cav1.3-/- and Cav1.3-/-Kir3.4-/- compared to WT 
